BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 9373453)

  • 1. Serum LH concentrations in hypogonadal men during transdermal testosterone replacement through scrotal skin: further evidence that ageing enhances testosterone negative feedback. The Testoderm Study Group.
    Winters SJ; Atkinson L
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):317-22. PubMed ID: 9373453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men.
    Meikle AW; Mazer NA; Moellmer JF; Stringham JD; Tolman KG; Sanders SW; Odell WD
    J Clin Endocrinol Metab; 1992 Mar; 74(3):623-8. PubMed ID: 1740497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.
    Jockenhövel F; Vogel E; Kreutzer M; Reinhardt W; Lederbogen S; Reinwein D
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):61-71. PubMed ID: 8796140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
    Winters SJ; Wang C;
    J Androl; 2010; 31(3):281-7. PubMed ID: 19959827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men.
    Arver S; Dobs AS; Meikle AW; Caramelli KE; Rajaram L; Sanders SW; Mazer NA
    Clin Endocrinol (Oxf); 1997 Dec; 47(6):727-37. PubMed ID: 9497881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.
    Swerdloff RS; Wang C; Cunningham G; Dobs A; Iranmanesh A; Matsumoto AM; Snyder PJ; Weber T; Longstreth J; Berman N
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4500-10. PubMed ID: 11134099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years.
    Behre HM; von Eckardstein S; Kliesch S; Nieschlag E
    Clin Endocrinol (Oxf); 1999 May; 50(5):629-35. PubMed ID: 10468929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men.
    Stuenkel CA; Dudley RE; Yen SS
    J Clin Endocrinol Metab; 1991 May; 72(5):1054-9. PubMed ID: 1902483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study.
    Wang C; Berman N; Longstreth JA; Chuapoco B; Hull L; Steiner B; Faulkner S; Dudley RE; Swerdloff RS
    J Clin Endocrinol Metab; 2000 Mar; 85(3):964-9. PubMed ID: 10720024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transdermal testosterone therapy in the treatment of male hypogonadism.
    Ahmed SR; Boucher AE; Manni A; Santen RJ; Bartholomew M; Demers LM
    J Clin Endocrinol Metab; 1988 Mar; 66(3):546-51. PubMed ID: 3350906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men.
    Jockenhövel F; Blum WF; Vogel E; Englaro P; Müller-Wieland D; Reinwein D; Rascher W; Krone W
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2510-3. PubMed ID: 9253326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 5α-reductase (SRD5A2) polymorphism is associated with serum testosterone and sex hormone-binding globulin in men, while aromatase (CYP19A1) polymorphisms are associated with oestradiol and luteinizing hormone reciprocally.
    Yeap BB; Knuiman MW; Handelsman DJ; Ho KKY; Hui J; Divitini ML; Arscott GM; McQuillan B; Hung J; Beilby JP
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):301-311. PubMed ID: 30353958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of primary hypogonadism in men by the transdermal administration of testosterone.
    Findlay JC; Place V; Snyder PJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):369-73. PubMed ID: 2493029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive impairment of testicular endocrine function in ageing men: Testosterone and dihydrotestosterone decrease, and luteinizing hormone increases, in men transitioning from the 8th to 9th decades of life.
    Yeap BB; Manning L; Chubb SAP; Handelsman DJ; Almeida OP; Hankey GJ; Flicker L
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):88-95. PubMed ID: 28945276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
    Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
    Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gonadotropin-suppressive activity of androgen is increased in elderly men.
    Winters SJ; Sherins RJ; Troen P
    Metabolism; 1984 Nov; 33(11):1052-9. PubMed ID: 6436639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.
    Tenover JS; Matsumoto AM; Plymate SR; Bremner WJ
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1118-26. PubMed ID: 3119649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
    Howell SJ; Radford JA; Adams JE; Smets EM; Warburton R; Shalet SM
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site- -a clinical research center study.
    Meikle AW; Arver S; Dobs AS; Sanders SW; Rajaram L; Mazer NA
    J Clin Endocrinol Metab; 1996 May; 81(5):1832-40. PubMed ID: 8626843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.